BioSpace News Archive

Lubrizol Advanced Materials’ TempRite® Engineered Polymers business, the global leader in CPVC resin and compounds, is pleased to announce it has successfully met all the sustainability requirements of +Vantage Vinyl™, an industry-wide sustainability initiative that engages companies across the entire U.S. vinyl value chain.

iAssay, Inc., and DDTD (Drugs & Diagnostics for Tropical Diseases), a 501(c)(3) nonprofit, have signed a Memorandum of Understanding (MOU). DDTD is a mission-driven organization to develop accurate, affordable, mass-market treatments and diagnostics for low-resourced and under-served organizations.

Calumeo, a privately-held medical device company dedicated to protecting frontline health care professionals, announced that Calumeo Clean, its point-of-care solution to process N95 masks for reuse, is now available in the U.S.

AIM ImmunoTech Inc. (NYSE American: AIM) today announced that Thomas K. Equels, Chief Executive Officer of AIM ImmunoTech, will be presenting at the Q1 Virtual Investor Summit. Event Q1 Investor Summit Date March 23-25th, 2021 Presentation March 24th @ 3:00 PM ET

Freeline Therapeutics Holdings plc (Nasdaq: FRLN) (the “Company” or “Freeline”), a clinical-stage biotechnology company developing transformative gene therapies for patients suffering from inherited systemic debilitating diseases, announced today the appointment of Colin A. Love, PhD, to its Board of Directors with immediate effect.

Hillrom (NYSE: HRC) announced today that its board of directors declared a 9 percent increase in the company’s quarterly dividend rate, from the previous rate of $0.22 per share to $0.24 per share. The fiscal second quarter 2021 quarterly dividend is payable on March 31, 2021, to shareholders of record as of the close of business on March 22, 2021.

Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a global leader in musculoskeletal healthcare, today announced that its Board of Directors has approved the payment of a quarterly cash dividend to stockholders for the first quarter of 2021.

- Published in the New England Journal of Medicine (NEJM), the REDUCE Study continues to show the largest reduction in recurrent ischemic stroke in all PFO shunt sizes over medical therapy alone.*,¹

Centene Corporation (NYSE: CNC) announced today that Katie Casso has been named Senior Vice President, Corporate Controller, effective April 1 , 2021. Christopher Isaak , Senior Vice President, Corporate Controller and Chief Accounting Officer announced his retirement, effective April 30, 2021 .

Bausch Health Companies Inc. announced that Chief Financial Officer Paul S. Herendeen will be appointed to the newly created role of Advisor to the chairman and chief executive officer of Bausch Health, effective June 1, 2021.